1. Israel Stocks

  2. •

    Technology

  3. •

    Software - Infrastructure
Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBT
Cellebrite DI Ltd.US flagNASDAQ Global Select
11.17
USD
+0.34
- -
2.81BMarket Cap

Total Valuation

Cellebrite DI Ltd. carries a market capitalization of 2.81B, placing it among publicly traded companies globally. Its enterprise value stands at 3.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.81B
Enterprise Value3.24B

Share Statistics

Cellebrite DI Ltd. currently has 250.79M shares outstanding.

Shares Outstanding250.79M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Cellebrite DI Ltd. trades at a trailing price-to-earnings ratio of 61.05. The price-to-sales ratio is 6.98, and the price-to-book ratio stands at 6.80.

PE Ratio61.05
PS Ratio6.98
PB Ratio6.80
P/TBV Ratio12.34
P/FCF Ratio19.68
P/OCF Ratio22.77

Enterprise Valuation

On an enterprise value basis, Cellebrite DI Ltd. trades at an EV/EBITDA multiple of 41.34 and an EV/FCF ratio of 17.38. The EV/Sales ratio of 6.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 58.04 provides insight into valuation relative to core operating earnings.

EV / Sales6.30
EV / EBITDA41.34
EV / EBIT58.04
EV / FCF17.38

Financial Position

Cellebrite DI Ltd. maintains a current ratio of 1.62, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

Current Ratio1.62
Quick Ratio1.52
Debt / Equity4.32
Debt / EBITDA0.30
Interest CoverageN/A

Financial Efficiency

Cellebrite DI Ltd. posts a return on equity of 12.42 and a return on invested capital of 8.79.

Return on Equity (ROE)12.42
Return on Assets (ROA)6.60
Return on Invested Capital (ROIC)8.79
Return on Capital Employed (ROCE)11.85
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover9.78

Taxes

Over the trailing twelve months, Cellebrite DI Ltd. has paid 16.62M in income taxes, reflecting an effective tax rate of 22.05.

Income Tax16.62M
Effective Tax Rate22.05

Stock Price Statistics

Cellebrite DI Ltd.'s stock has declined approximately -42.15026% over the past 52 weeks. The 50-day moving average sits at 11.89, while the 200-day moving average is 13.78.

Beta (5Y)N/A
52-Week Price Change-42.15026%
50-Day Moving Average11.89
200-Day Moving Average13.78
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Cellebrite DI Ltd. generated 514.29M in revenue and converted that into 58.76M in net income, yielding earnings per share of 0.23. EBITDA reached 78.43M, while operating income came in at 55.86M.

Revenue514.29M
Gross Profit426.66M
Operating Income55.86M
Pretax Income75.38M
Net Income58.76M
EBITDA78.43M
EBIT55.86M
Earnings Per Share (EPS)0.23

Balance Sheet

Cellebrite DI Ltd. holds 442.53M in cash and equivalents against 23.23M in total debt, resulting in a net debt position of -141.25M. Total book value stands at 538.10M, with working capital of 225.47M providing operational flexibility.

Cash & Cash Equivalents442.53M
Total Debt23.23M
Net Debt-141.25M
Equity (Book Value)538.10M
Book Value Per Share2.15
Working Capital225.47M

Cash Flow

Cellebrite DI Ltd. produced 157.56M in operating cash flow over the past twelve months. After subtracting -29.01M in capital expenditures, free cash flow totaled 128.55M - equivalent to 0.52 per share.

Operating Cash Flow157.56M
Capital Expenditures-29.01M
Free Cash Flow128.55M
FCF Per Share0.52

Margins

Cellebrite DI Ltd. operates with a gross margin of 82.96, reflecting its pricing power and cost economics. The operating margin of 10.86 and net profit margin of 11.43 provide insight into operational efficiency.

Gross Margin82.96
Operating Margin10.86
Pretax Margin14.66
Profit Margin11.43
EBITDA Margin15.25

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-0.40
FCF Yield5.08

Scores

Cellebrite DI Ltd. posts an Altman Z-Score of 5.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.97